Heugenius Pty Ltd

Status: Registered
Australian Company Number: 123919040
Australian Business Number: 55123919040
Registration date: 13th February 2007
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary superannuation trustee company
last updated

Description

Heugenius Pty Ltd is a limited by shares, proprietary superannuation trustee company, Australian proprietary company. This corporation was registered on 2007-02-13 and was issued with the 123919040 ACN. Its Australian Business Number is 55123919040. Since 2007-02-13, the company is headquartered in QLD, post code 4562. Heugenius Pty Ltd has been using the Heugenius Pty Ltd trading name since 2007-02-13 (it should be noted that the Australian Business Register no longer collects or updates trading names). In total the company used 1 trading name. The above data comes from the ABN database which was updated on 2007-02-13.

Details for ABN 55123919040

Type: Australian Private Company

ABN Status

Status From To
Active 13th February 2007 current

Main Name

Name From To
Heugenius Pty Ltd 13th February 2007 current

Trading Names

Name From To
Heugenius Pty Ltd 13th February 2007 current

Main Location

Location From To
QLD 4562 13th February 2007 current

Advertisements

Find company

QLD 4562 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.